Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12372799rdf:typepubmed:Citationlld:pubmed
pubmed-article:12372799lifeskim:mentionsumls-concept:C1267092lld:lifeskim
pubmed-article:12372799lifeskim:mentionsumls-concept:C0221464lld:lifeskim
pubmed-article:12372799lifeskim:mentionsumls-concept:C0027103lld:lifeskim
pubmed-article:12372799lifeskim:mentionsumls-concept:C0851285lld:lifeskim
pubmed-article:12372799pubmed:issue5lld:pubmed
pubmed-article:12372799pubmed:dateCreated2002-10-9lld:pubmed
pubmed-article:12372799pubmed:abstractTextThe initiation of contractile force in arterial smooth muscle (SM) is believed to be regulated by the intracellular Ca2+ concentration and SM myosin type II phosphorylation. We tested the hypothesis that SM myosin type II operates as a molecular motor protein in electromechanical, but not in protein kinase C (PKC)-induced, contraction of small resistance-sized cerebral arteries. We utilized a SM type II myosin heavy chain (MHC) knockout mouse model and measured arterial wall Ca2+ concentration ([Ca2+](i)) and the diameter of pressurized cerebral arteries (30-100 microm) by means of digital fluorescence video imaging. Intravasal pressure elevation caused a graded [Ca2+](i) increase and constricted cerebral arteries of neonatal wild-type mice by 20-30%. In contrast, intravasal pressure elevation caused a graded increase of [Ca2+](i) without constriction in (-/-) MHC-deficient arteries. KCl (60 mM) induced a further [Ca2+](i) increase but failed to induce vasoconstriction of (-/-) MHC-deficient cerebral arteries. Activation of PKC by phorbol ester (phorbol 12-myristate 13-acetate, 100 nM) induced a strong, sustained constriction of (-/-) MHC-deficient cerebral arteries without changing [Ca2+](i). These results demonstrate a major role for SM type II myosin in the development of myogenic tone and Ca2+ -dependent constriction of resistance-sized cerebral arteries. In contrast, the sustained contractile response did not depend on myosin and intracellular Ca2+ but instead depended on PKC. We suggest that SM myosin type II operates as a molecular motor protein in the development of myogenic tone but not in pharmacomechanical coupling by PKC in cerebral arteries. Thus PKC-dependent phosphorylation of cytoskeletal proteins may be responsible for sustained contraction in vascular SM.lld:pubmed
pubmed-article:12372799pubmed:languageenglld:pubmed
pubmed-article:12372799pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12372799pubmed:citationSubsetIMlld:pubmed
pubmed-article:12372799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12372799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12372799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12372799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12372799pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12372799pubmed:statusMEDLINElld:pubmed
pubmed-article:12372799pubmed:monthNovlld:pubmed
pubmed-article:12372799pubmed:issn0363-6143lld:pubmed
pubmed-article:12372799pubmed:authorpubmed-author:LuftFriedrich...lld:pubmed
pubmed-article:12372799pubmed:authorpubmed-author:HallerHermann...lld:pubmed
pubmed-article:12372799pubmed:authorpubmed-author:GollaschMaikMlld:pubmed
pubmed-article:12372799pubmed:authorpubmed-author:LöhnMatthiasMlld:pubmed
pubmed-article:12372799pubmed:authorpubmed-author:KämpfDietmarDlld:pubmed
pubmed-article:12372799pubmed:authorpubmed-author:Gui-XuanChaiClld:pubmed
pubmed-article:12372799pubmed:issnTypePrintlld:pubmed
pubmed-article:12372799pubmed:volume283lld:pubmed
pubmed-article:12372799pubmed:ownerNLMlld:pubmed
pubmed-article:12372799pubmed:authorsCompleteYlld:pubmed
pubmed-article:12372799pubmed:paginationC1383-9lld:pubmed
pubmed-article:12372799pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:meshHeadingpubmed-meshheading:12372799...lld:pubmed
pubmed-article:12372799pubmed:year2002lld:pubmed
pubmed-article:12372799pubmed:articleTitleRegulation of arterial tone by smooth muscle myosin type II.lld:pubmed
pubmed-article:12372799pubmed:affiliationFranz Volhard Clinic and Max Delbrück Center for Molecular Medicine, Charité University Hospital, Humboldt University of Berlin, 13125 Berlin, Germany.lld:pubmed
pubmed-article:12372799pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12372799pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:17880entrezgene:pubmedpubmed-article:12372799lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:12372799lld:pubmed